Active Not RecruitingNCT06881810
Enhancing Social Skills in Schizophrenia Spectrum Disorders - Oxytocin as add-on to Psychosocial Treatment
Medication studyAges 18–64Germany
Understand this study
Who could participate?
This study is for people with schizophrenia. Listed age limits: 18 years to 64 years. Other eligibility criteria apply.
- Listed locations
- MannheimSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: August 29, 2024
- Recruitment status
- Active Not Recruiting
- Enrollment listed in the registry
- 98
- Sponsor
- Central Institute of Mental Health, Mannheim
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug, Other
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Germany
- Age range
- From 18 Years to 64 Years
- Official registry ID
- NCT06881810
- Official title
Show the full official title
Enhancing Social Skills in Schizophrenia Spectrum Disorders - Two-arm, Double-blind, Randomized Clinical Trial Investigating Oxytocin vs. Placebo as an add-on to an Individualized Psychosocial Treatment (OXY-APS)
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Mannheim
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Central Institute of Mental Health, Mannheim, a research institute.
Does this study involve medication?
Yes. The study involves medication, including Oxytocin nasal spray.
Who can participate?
This study is for people with schizophrenia. Listed age limits: 18 years to 64 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as active, but no longer recruiting.
